INBX
Inhibrx, Inc. Common Stock
INBX
INBX
Delisted
INBX was delisted on the 29th of May, 2024.
108 hedge funds and large institutions have $692M invested in Inhibrx, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 37 increasing their positions, 34 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
22% less capital invested
Capital invested by funds: $886M → $692M (-$194M)
35% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 23
Holders
108
Holding in Top 10
1
Calls
$4.19M
Puts
$93K
Top Buyers
| 1 | +$33.1M | |
| 2 | +$5.93M | |
| 3 | +$5.69M | |
| 4 |
Renaissance Technologies
New York
|
+$4.03M |
| 5 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$3.04M |
Top Sellers
| 1 | -$15.1M | |
| 2 | -$9.69M | |
| 3 | -$8.13M | |
| 4 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$3.73M |
| 5 |
TCM
Tybourne Capital Management
Hong Kong
|
-$2.36M |